Why the study?
Does light sedation compared to deep sedation reduce 1-year mortality in elderly patients undergoing emergency hip fracture surgery under spinal anesthesia?
Does light sedation compared to deep sedation reduce 1-year mortality in elderly patients undergoing emergency hip fracture surgery under spinal anesthesia?
Answers are grounded in this paper and cite their sources.
This editorial highlights evidence that lighter sedation during spinal anesthesia for emergency hip fracture surgery in elderly patients with comorbidities significantly reduces 1-year mortality compared to deep sedation.
“I have spread my dreams under your feet; Tread softly because you tread on my dreams.” W. B. Yeats (1865–1939) “He Wishes For the Cloths of Heaven” From the Collected Works of W. B. Yeats The modern practice of anesthesia is far removed from the era of manual blood pressure readings and feeling the pulse. Advancements in our specialty over the last 4 decades have considerably expanded the horizons and safety of patient care.1 Older patients and those with serious comorbidities are increasingly anesthetized for routine procedures, ambulatory, and office-based surgery. The availability of sophisticated monitoring systems and “cleaner” drugs might lead one to a somewhat smug sense of accomplishment. “Where are we now with anesthesia?” is not an unreasonable enquiry. It is therefore a bit unsettling when findings from recent articles suggest that all may not be so positive. As well as looking forward, anesthesiologists may have to start looking more closely at their current practices, particularly in certain patient groups. Concerns that anesthesia in young children may affect cognitive function and learning in later life,2 that general anesthesia may influence cancer recurrence compared with regional techniques,3 and that cumulative periods of deep anesthesia (defined using processed electroencephalography) could result in greater mortality4–7 have stirred the comfortable position anesthesia currently holds. A reactive defense is that these studies have methodological failings like nonrandomization or inappropriate statistical analysis, or that the outcomes measured reflect an “other” preexisting disease or environmental factors. Often the anesthetic intervention seems minor in the scale of things, of too short a duration to cause long-term or permanent harm. The reality is that there is already good clinical evidence from prospective randomized trials that “minor” and short duration changes in anesthesia practice can improve patient outcomes.8 Higher levels of inspired oxygen reduce wound infection rates after colorectal surgery.9 Maintaining normothermia during anesthesia reduces blood loss,10 myocardial ischemia,11 and wound infections.12 The intraoperative use of IV lidocaine reduces the incidence of persistent postsurgical pain after breast surgery.13 We currently lack prospective randomized data regarding the effect of depth of anesthesia (as defined by Bispectral Index [BIS] levels) on mortality. In this issue of the Journal, Brown et al14 from John Hopkins Medical Institutions, Baltimore, MD, present the results of a study comprising 114 patients aged ≥65 years undergoing hip fracture surgery under spinal anesthesia who received either light or deep sedation as defined by BIS levels of >80 or approximately 50, respectively. Patients were randomized to either BIS level. The authors demonstrate that those patients with serious comorbidities (Charlson comorbidity index >4) randomized to light sedation had a lower 1-year mortality of 22.2% compared with 43.6% for those receiving deep sedation. The hazard ratio was 0.43 [95% confidence interval, 0.19–0.97], decreasing to 0.33 [95% confidence interval, 0.12–0.94] among patients with a Charlson index >6. There was no difference among healthier patients (Charlson index <4).15 There are a few points worthy of particular note, especially in any study looking at depth of sedation or anesthesia as determined by BIS values and a subsequent effect on mortality. First, the patients were elderly patients with a mean age of 81.7 years. All patients were undergoing emergency surgery for hip fracture repair. The median ASA physical status was III. These are all recognized risk factors for increased postoperative mortality.16 Importantly, both groups were similar with regard to these confounders. The only differences between the groups other than BIS levels were that those in the deep sedation group received a median of 8.1 mg/kg propofol vs 1.3 mg/kg for the light group and a median of 2 mg midazolam compared with 10 mg in the light group. The authors, limited by a short Discussion required of a Brief Report, do not provide any explanation. Why might older patients undergoing emergency surgery under spinal anesthesia with different depths of sedation have a different 1-year mortality rate? We know that propofol causes significantly more hypotension than midazolam when used for sedation in older patients undergoing a spinal anesthetic17; however, there were no differences in duration of hypotension in this study (P = 0.76). The effects of electroencephalogram burst suppression, found at lower BIS values, on increased mortality have been demonstrated in critically ill patients18 and may play a role. We might postulate that clinical levels of anesthetic agents such as propofol and volatile agents acting at γ-aminobutyric acid receptors may be neurotoxic to developing or “deteriorating” brains.16 There are now experimental data19 to show this as well as clinical data that patients at the extremes of life have postoperative cognitive problems after general anesthesia.2,20,21 Regardless of underlying mechanism, we are presented with a study that demonstrates the possibility of a link between mortality and level of sedation when combined with spinal anesthesia. So what does the reader do with this new information? A 2005 study by Monk et al4 in this journal demonstrating an association between BIS values <45 and increased 1-year mortality in noncardiac surgery generated considerable debate including a reproach of the Editorial Board.22 Dismissing this current study on the grounds of bias and unknown confounders is not easy. Unlike previous nonrandomized studies4–7 that have demonstrated increased mortality in those with low BIS (<45) values, the randomization process in this study14 means that the chances that low BIS values merely represent sicker patients who are therefore at greater risk of dying are remote. Those seeking statistical flaws in this study may point out that randomization originally occurred in this study to compare the incidence of delirium not mortality in patients undergoing spinal anesthesia under light or deep sedation. Returning to the original randomized data to determine mortality rates as opposed to delirium is appropriate and statistically valid. The debate, controversy, and ongoing research on the question “does deeper general anesthesia result in greater mortality” cannot be answered here. The data from those studies4–7 leave us with an association that compels us to look further and call for further studies. This is not the case with the findings that Brown et al14 present us with. Their data are valid, and their findings are of immense clinical importance. Many of us will provide sedation for older patients with multiple comorbidities undergoing emergency hip surgery with spinal anesthesia this week. This article suggests that those having deeper sedation with high doses of propofol are more likely to die than if lighter sedation is used. Why this might be the case needs research, but that must not delay anesthesiologists from reflecting on their clinical practice today. Unlike the potential increased risk of awareness with “lighter” general anesthesia, there is no such serious outcome arising from changing from deep to light sedation with spinal anesthesia. Anxiety and patient comfort are multifactorial and can often be managed through a variety of means including lighter sedation, reassurance, and positioning, without apparent additional risk to the patient. As anesthesiologists, we cannot change the age, ASA physical status, or comorbidities of our patients; we can however change how softly we tread on their dreams. DISCLOSURES Name: Stephen Mannion, MD, MRCPI, FCARCSI. Contribution: This author helped design the study, conduct the study, analyze the data, write the manuscript, and conclusion. Attestation: Stephen Mannion approved the final manuscript. Name: Peter Lee, MD, FCARCSI. Contribution: This author helped design the study, conduct the study, analyze the data, write the manuscript, and conclusion. Attestation: Peter Lee approved the final manuscript. This manuscript was handled by: Sorin J. Brull, MD, FCARCSI (Hon).
No takes yet. Share an insight, caveat, or question.
Mannion et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: